McKesson, Merck back Atropos Health's $33M round to accelerate drug development with AI

Atropos Health raises $33 million in Series B funding to revolutionize healthcare with AI-powered clinical evidence generation, aiming to personalize medical decision-making and accelerate drug development.

Related Keywords

Geneva ,Genè ,Switzerland ,Brigham Hyde ,Atropos Health ,Venturebeat Terms Of Service ,Mckesson ,Cencora Ventures ,Silicon Valley Based ,